Tech Company Financing Transactions

PsiThera Funding Round

Lightstone Ventures, Samsara BioCapital and Eurofarma participated in a $47.5 million Series A venture round for PsiThera. The round was announced on 12/10/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

66 Galen Street 202
Watertown, MA 02472
USA

Phone

Undisclosed

Website

www.psithera.com

Email Address

Not Recorded

Overview

PsiThera is advancing programs across multiple targets from the tumor necrosis factor (TNF) superfamily and beyond, where no oral therapies currently exist. These could become the first oral treatments in their categories. Our pipeline targets represent major opportunities to bring biologic-like efficacy to patients--without injections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eric Shaff

        

Browse more venture capital transactions:

Prev: 12/10/2025: GoDutch venture capital transaction
Next: 12/10/2025: fal - features and labels venture capital transaction

Share this article

About Database of VC Transactions

We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary